{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:15:19Z","timestamp":1789755319631,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2022RC1229"],"award-info":[{"award-number":["2022RC1229"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104306"],"award-info":[{"award-number":["82104306"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ40694"],"award-info":[{"award-number":["2022JJ40694"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jpba.2023.115928","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T02:26:03Z","timestamp":1702952763000},"page":"115928","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Development and validation of a UPLC-PDA method for quantifying ceftazidime in dried blood spots"],"prefix":"10.1016","volume":"239","author":[{"given":"Jianmei","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpba.2023.115928_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-199549040-00008","article-title":"Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy","volume":"49","author":"Rains","year":"1995","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.jpba.2023.115928_bib2","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3390\/antibiotics12061072","article-title":"Use of newer and repurposed antibiotics against gram-negative bacteria in neonates","volume":"12","author":"Kontou","year":"2023","journal-title":"Antibiotics"},{"issue":"3","key":"10.1016\/j.jpba.2023.115928_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1542\/peds.2013-4060","article-title":"D. American Academy of Pediatrics Committee on, Off-label use of drugs in children","volume":"133","author":"Frattarelli","year":"2014","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jpba.2023.115928_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5104","article-title":"Determination of ceftazidime in plasma by RP-HPLC and ultraviolet dete ction","volume":"35","author":"Bergman","year":"2021","journal-title":"Biomed. Chromatogr:BMC"},{"issue":"Suppl 1","key":"10.1016\/j.jpba.2023.115928_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00228-009-0782-9","article-title":"The role of population PK-PD modeling in pediatric clinical research","volume":"67","author":"De Cock","year":"2011","journal-title":"Eur. J. Clin. Pharm."},{"issue":"5","key":"10.1016\/j.jpba.2023.115928_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/dta.1646","article-title":"Dried blood spots: concepts, present status, and future perspectives i n bioanalysis","volume":"6","author":"Sharma","year":"2014","journal-title":"Drug Test. Anal."},{"issue":"3","key":"10.1016\/j.jpba.2023.115928_bib7","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FTD.0000000000000864","article-title":"Alternative sampling devices to collect dried blood microsamples: state-of-the-art","volume":"43","author":"Delahaye","year":"2021","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2023.115928_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2015.04.008","article-title":"Dried blood spots for monitoring and individualization of antiepileptic drug treatment","volume":"75","author":"Milosheska","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2023.115928_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122905","article-title":"A simplified method for bortezomib determination using dried blood spots in combination with liquid chromatography\/tandem mass spectrometry","volume":"1181","author":"Guo","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"8","key":"10.1016\/j.jpba.2023.115928_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/17512433.2023.2224562","article-title":"Dried blood spot sampling for therapeutic drug monitoring: challenges and opportunities","volume":"16","author":"M\u00fcller","year":"2023","journal-title":"Expert Rev. Clin. Pharm."},{"key":"10.1016\/j.jpba.2023.115928_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.340797","article-title":"Liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of immunosuppressants and creatinine from a single dried blood spot using the Capitainer\u00ae qDBS device","volume":"1242","author":"Deprez","year":"2023","journal-title":"Anal. Chim. Acta"},{"issue":"3","key":"10.1016\/j.jpba.2023.115928_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5010","article-title":"Simultaneous determination of six antibiotics in human serum by high-performance liquid chromatography with UV detection","volume":"35","author":"Roth","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2023.115928_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115319","article-title":"Simultaneous determination of ceftazidime and pyridine in human plasma by LC-UV","volume":"228","author":"Nguyen","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2023.115928_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123164","article-title":"Quantification of ceftazidime\/avibactam in human plasma and dried blood spots: Implications on stability and sample transport","volume":"1193","author":"Martens-Lobenhoffer","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2023.115928_bib15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jpba.2017.07.033","article-title":"Volumetric adsorptive microsampling-liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of four antibiotics in human blood: method development, validation and comparison with dried blood spot","volume":"145","author":"Barco","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"5","key":"10.1016\/j.jpba.2023.115928_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01707-22","article-title":"Population pharmacokinetics and dosing optimization of ceftazidime in term asphyxiated neonates during controlled therapeutic hypothermia","volume":"67","author":"van der Veer","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.jpba.2023.115928_bib17","first-page":"371","article-title":"UPLC: a preeminent technique in pharmaceutical analysis","volume":"69","author":"Kumar","year":"2012","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.jpba.2023.115928_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105868","article-title":"Population pharmacokinetics-pharmacodynamics of ceftazidime in neonates and young infants: Dosing optimization for neonatal sepsis","volume":"163","author":"Li","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.jpba.2023.115928_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02486-17","article-title":"Population pharmacokinetics and dosing optimization of ceftazidime in infants","volume":"62","author":"Shi","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"14","key":"10.1016\/j.jpba.2023.115928_bib20","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.4155\/bio.11.132","article-title":"EBF recommendation on the validation of bioanalytical methods for dried blood spots","volume":"3","author":"Timmerman","year":"2011","journal-title":"Bioanalysis"},{"issue":"17","key":"10.1016\/j.jpba.2023.115928_bib21","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.4155\/bio.13.173","article-title":"F. European bioanalysis, update of the EBF recommendation for the use of DBS in regulated bioan alysis integrating the conclusions from the EBF DBS-microsampling consortium","volume":"5","author":"Timmerman","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2023.115928_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114558","article-title":"An UPLC-PDA assay for simultaneous determination of seven antibiotics in human plasma","volume":"210","author":"Xie","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jpba.2023.115928_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3390\/antibiotics12020199","article-title":"A validated UHPLC-MS\/MS method to quantify eight antibiotics in quantitative dried blood spots in support of pharmacokinetic studies in neonates","volume":"12","author":"Liu","year":"2023","journal-title":"Antibiotics"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523006970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:34:18Z","timestamp":1760002458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523006970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"alternative-id":["S0731708523006970"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115928","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a UPLC-PDA method for quantifying ceftazidime in dried blood spots","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115928","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115928"}}